[Neuroleptic malignant syndrome--3 case reports].
An account is given of three patients who exhibited a malignant neuroleptic syndrome after the administration of neuroplegics. Like other authors, we identified typical elicitation factors and clinical characteristics. In one case a catatonic dilemma with lethal issue was observed. In the final case dealt with in this paper, the renewed application of neuroplegics following the termination of the malignant neuroleptic syndrome was tolerated without complications, whereas in the case of an epileptic patient with damage to the brain, the malignant neuroleptic syndrome returned upon dosage increase.
Simmich
T
T
Klinik für Neurologie und Psychiatrie, Medizinischen Akademie Carl Gustav Carus Dresden.
Müller
J
J
Bach
O
O
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents